{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T14:56:20Z","timestamp":1790088980430,"version":"4.0.1"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_jpm-2015-0437_s_999_w2aab3b7b1b1b6b1aab1c17b1Aa\">\n                  <jats:title id=\"d1389240e541_w2aab3b7b1b1b6b1aab1c17b1aAa\">Aim:<\/jats:title>\n                  <jats:p>Owing to its mysterious etiology, pathogenesis of preeclampsia (PE) remains controversial. Here we aimed to compare the levels of an angiogenesis marker, split and hairy related protein-1 (SHARP1), in PE vs. normal pregnancy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2015-0437_s_998_w2aab3b7b1b1b6b1aab1c17b2Aa\">\n                  <jats:title id=\"d1389240e549_w2aab3b7b1b1b6b1aab1c17b2aAa\">Methods:<\/jats:title>\n                  <jats:p>Thirty-one patients with early-onset PE (EOPE), 26 patients with late-onset PE (LOPE), and 33 patients as a control group were recruited for this study in a tertiary referral center in Ankara, Turkey. Maternal venous SHARP1 levels and individual characteristics of the three groups were compared.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2015-0437_s_997_w2aab3b7b1b1b6b1aab1c17b3Aa\">\n                  <jats:title id=\"d1389240e557_w2aab3b7b1b1b6b1aab1c17b3aAa\">Results:<\/jats:title>\n                  <jats:p>Age and body mass indices were similar among the three groups. SHARP1 levels in patients with PE (27.7\u00b113.2 ng\/mL) were significantly lower than in the control group (34.7\u00b117 ng\/mL) (P=0.006). Additionally, SHARP1 levels were significantly different among patients in EOPE, LOPE, and control groups (P=0.022). Birth weights and Apgar scores in patients in EOPE group were significantly lower than the other two groups and showed a gradual increase from the EOPE group to the LOPE and the control group. Binary logistic regression method demonstrated that maternal venous SHARP1 level was a risk factor for PE.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_jpm-2015-0437_s_996_w2aab3b7b1b1b6b1aab1c17b4Aa\">\n                  <jats:title id=\"d1389240e565_w2aab3b7b1b1b6b1aab1c17b4aAa\">Conclusions:<\/jats:title>\n                  <jats:p>Maternal venous SHARP1 levels in PE are lower than a normal pregnancy. Its clinical applicability and role as a candidate for making sense of the distinctive pathogenesis of the EOPE and LOPE remain to be elucidated.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/jpm-2015-0437","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T10:01:10Z","timestamp":1479204070000},"page":"803-808","source":"Crossref","is-referenced-by-count":4,"title":["Maternal venous SHARP1 levels in preeclampsia"],"prefix":"10.1515","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1137-7017","authenticated-orcid":false,"given":"Ali Ozgur","family":"Ersoy","sequence":"first","affiliation":[{"name":"Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Talatpasa Bulv. Hamamonu, 06230, Altindag , Ankara , Turkey , Tel.: +905056579157, Fax: +903123064931"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efser","family":"Oztas","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sibel","family":"Ozler","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aytekin","family":"Tokmak","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebru","family":"Ersoy","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Ergin","sequence":"additional","affiliation":[{"name":"Department of Biochemistry , 25 December State Hospital , Gaziantep , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuri","family":"Danisman","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology , Zekai Tahir Burak Women\u2019s Health Care, Training and Research Hospital , Ankara , Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2016,11,15]]},"reference":[{"key":"2023040100153365698_j_jpm-2015-0437_ref_001_w2aab3b7b1b1b6b1ab1b5b1Aa","doi-asserted-by":"crossref","unstructured":"Lenfant C, National Education Program Working Group on High Blood Pressure in Pregnancy. Working group report on high blood pressure in pregnancy. J Clin Hypertens (Greenwich). 2001;3:75\u201388.10.1111\/j.1524-6175.2001.00458.x","DOI":"10.1111\/j.1524-6175.2001.00458.x"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_002_w2aab3b7b1b1b6b1ab1b5b2Aa","doi-asserted-by":"crossref","unstructured":"Roberts JM, Gammil HS. Preeclampsia: recent insights. Hypertension. 2005;46:1243\u20139.1623051010.1161\/01.HYP.0000188408.49896.c5","DOI":"10.1161\/01.HYP.0000188408.49896.c5"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_003_w2aab3b7b1b1b6b1ab1b5b3Aa","doi-asserted-by":"crossref","unstructured":"Stanczuk GA, Mccoy MJ, Hutchinson IV, Sibanda EN. The genetic predisposition to produce high levels of TGF-beta1 impacts on the severity of eclampsia\/pre-eclampsia. Acta Obstet Gynecol Scand. 2007;86:903\u20138.10.1080\/0001634070141694517653872","DOI":"10.1080\/00016340701416945"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_004_w2aab3b7b1b1b6b1ab1b5b4Aa","doi-asserted-by":"crossref","unstructured":"Laresgoiti-Servitje E, Gomez-Lopez N, Olson DM. An immunological insight into the origins of pre-eclampsia. Hum Reprod Update. 2010;16:510\u201324.10.1093\/humupd\/dmq00720388637","DOI":"10.1093\/humupd\/dmq007"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_005_w2aab3b7b1b1b6b1ab1b5b5Aa","doi-asserted-by":"crossref","unstructured":"Shamshirsaz AA, Paidas M, Krikun G. Preeclampsia, hypoxia, thrombosis, and inflammation. J Pregnancy. 2012;2012:374047.22175023","DOI":"10.1155\/2012\/374047"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_006_w2aab3b7b1b1b6b1ab1b5b6Aa","doi-asserted-by":"crossref","unstructured":"Tal R. The role of hypoxia and hypoxia-inducible factor-1alpha in preeclampsia pathogenesis. Biol Reprod. 2012;87:134.23034156","DOI":"10.1095\/biolreprod.112.102723"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_007_w2aab3b7b1b1b6b1ab1b5b7Aa","doi-asserted-by":"crossref","unstructured":"Liu W, Wang SJ, Lin QD. Study on the expressions of PHD and HIF in placentas from normal pregnant women and patients with preeclampsia. Int J Biol Sci. 2014;10:278\u201384.10.7150\/ijbs.637524644426","DOI":"10.7150\/ijbs.6375"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_008_w2aab3b7b1b1b6b1ab1b5b8Aa","doi-asserted-by":"crossref","unstructured":"Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487:380\u20134.10.1038\/nature1120722801492","DOI":"10.1038\/nature11207"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_009_w2aab3b7b1b1b6b1ab1b5b9Aa","doi-asserted-by":"crossref","unstructured":"Fujimoto K, Shen M, Noshiro M, Matsubara K, Shingu S, Honda K, et al. Molecular cloning and characterization of DEC2, a new member of basic helix-loop-helix proteins. Biochem Biophys Res Commun. 2001;280:164\u201371.1116249410.1006\/bbrc.2000.4133","DOI":"10.1006\/bbrc.2000.4133"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_010_w2aab3b7b1b1b6b1ab1b5c10Aa","doi-asserted-by":"crossref","unstructured":"Rossner MJ, Oster H, Wichert SP, Reinecke L, Wehr MC, Reinecke J, et al. Disturbed clockwork resetting in Sharp-1 and Sharp-2 single and double mutant mice. PLoS One. 2008;3:e2762.10.1371\/journal.pone.000276218648504","DOI":"10.1371\/journal.pone.0002762"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_011_w2aab3b7b1b1b6b1ab1b5c11Aa","doi-asserted-by":"crossref","unstructured":"Baier PC, Brz\u00f3zka MM, Shahmoradi A, Reinecke L, Kroos C, Wichert SP, et al. Mice lacking the circadian modulators SHARP1 and SHARP2 display altered sleep and mixed state endophenotypes of psychiatric disorders. PLoS One. 2014;9:e110310.2534047310.1371\/journal.pone.0110310","DOI":"10.1371\/journal.pone.0110310"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_012_w2aab3b7b1b1b6b1ab1b5c12Aa","doi-asserted-by":"crossref","unstructured":"Andraweera PH, Dekker GA, Roberts CT. The vascular endothelial growth factor family in adverse pregnancy outcomes. Hum Reprod Update. 2012;18:436\u201357.2249525910.1093\/humupd\/dms011","DOI":"10.1093\/humupd\/dms011"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_013_w2aab3b7b1b1b6b1ab1b5c13Aa","doi-asserted-by":"crossref","unstructured":"Khodzhaeva ZS, Kogan YA, Shmakov RG, Klimenchenko NI, Akatyeva AS, Vavina OV, et al. Clinical and pathogenetic features of early- and late-onset pre-eclampsia. Matern Fetal Neonatal Med. 2016;29:2980\u20136.","DOI":"10.3109\/14767058.2015.1111332"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_014_w2aab3b7b1b1b6b1ab1b5c14Aa","doi-asserted-by":"crossref","unstructured":"National High Blood Pressure Education Program Working Group. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1\u201322.","DOI":"10.1067\/mob.2000.107928"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_015_w2aab3b7b1b1b6b1ab1b5c15Aa","doi-asserted-by":"crossref","unstructured":"Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010;376:631\u201344.10.1016\/S0140-6736(10)60279-620598363","DOI":"10.1016\/S0140-6736(10)60279-6"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_016_w2aab3b7b1b1b6b1ab1b5c16Aa","doi-asserted-by":"crossref","unstructured":"World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. J Am Med Assoc. 2013;310:2191\u20134.","DOI":"10.1001\/jama.2013.281053"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_017_w2aab3b7b1b1b6b1ab1b5c17Aa","doi-asserted-by":"crossref","unstructured":"Osol G, Mandala M. Maternal uterine vascular remodeling during pregnancy. Physiology (Bethesda). 2009;24:58\u201371.19196652","DOI":"10.1152\/physiol.00033.2008"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_018_w2aab3b7b1b1b6b1ab1b5c18Aa","doi-asserted-by":"crossref","unstructured":"Silasi M, Cohen B, Karumanchi SA, Rana S. Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am. 2010;37:239\u201353.10.1016\/j.ogc.2010.02.01320685551","DOI":"10.1016\/j.ogc.2010.02.013"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_019_w2aab3b7b1b1b6b1ab1b5c19Aa","doi-asserted-by":"crossref","unstructured":"Rios DR, Alpoim PN, Godoi LC, Perucci LO, de Sousa LP, Gomes KB, et al. Increased Levels of sENG and sVCAM-1 and Decreased Levels of VEGF in Severe Preeclampsia. Am J Hypertens. 2016;29:1307\u201310.2647608310.1093\/ajh\/hpv170","DOI":"10.1093\/ajh\/hpv170"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_020_w2aab3b7b1b1b6b1ab1b5c20Aa","doi-asserted-by":"crossref","unstructured":"Liao Y, Lu W, Che Q, Yang T, Qiu H, Zhang H, et al. SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1\u03b1 level. PLoS One. 2014;9:e99907.10.1371\/journal.pone.009990724918449","DOI":"10.1371\/journal.pone.0099907"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_021_w2aab3b7b1b1b6b1ab1b5c21Aa","doi-asserted-by":"crossref","unstructured":"Montagner M, Enzo E, Forcato M, Zanconato F, Parenti A, Rampazzo E, et al. SHARP1 suppresses breast cancer metastasis by promoting degradation of hypoxia-inducible factors. Nature. 2012;487:380\u20134.10.1038\/nature1120722801492","DOI":"10.1038\/nature11207"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_022_w2aab3b7b1b1b6b1ab1b5c22Aa","doi-asserted-by":"crossref","unstructured":"Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med. 2001;7:345\u201350.1151699410.1016\/S1471-4914(01)02090-1","DOI":"10.1016\/S1471-4914(01)02090-1"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_023_w2aab3b7b1b1b6b1ab1b5c23Aa","doi-asserted-by":"crossref","unstructured":"Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Imaizumi T, Imanaka T, et al. Basic-helix-loop-helix (bHLH) transcription factor DEC2 negatively regulates vascular endothelial growth factor expression. Genes Cells. 2008;13:131\u201344.10.1111\/j.1365-2443.2007.01153.x18233956","DOI":"10.1111\/j.1365-2443.2007.01153.x"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_024_w2aab3b7b1b1b6b1ab1b5c24Aa","doi-asserted-by":"crossref","unstructured":"Gordon LK, Kiyohara M, Fu M, Braun J, Dhawan P, Chan A, et al. EMP2 regulates angiogenesis in endometrial cancer cells through induction of VEGF. Oncogene. 2013;32:5369\u201376.2333433110.1038\/onc.2012.622","DOI":"10.1038\/onc.2012.622"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_025_w2aab3b7b1b1b6b1ab1b5c25Aa","doi-asserted-by":"crossref","unstructured":"Ashur-Fabian O, Yerushalmi GM, Mazaki-Tovi S, Steinberg DM, Goldshtein I, Yackobovitch-Gavan M, et al. Cell free expression of hif1\u03b1 and p21 in maternal peripheral blood as a marker for preeclampsia and fetal growth restriction. PLoS One. 2012;7:e37273.10.1371\/journal.pone.003727322615960","DOI":"10.1371\/journal.pone.0037273"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_026_w2aab3b7b1b1b6b1ab1b5c26Aa","doi-asserted-by":"crossref","unstructured":"Wang A, Rana S, Karumanchi SA. Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology. 2009;24:147\u201358.10.1152\/physiol.00043.2008","DOI":"10.1152\/physiol.00043.2008"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_027_w2aab3b7b1b1b6b1ab1b5c27Aa","doi-asserted-by":"crossref","unstructured":"Wu Y, Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, et al. Basic helixloop-helix transcription factors DEC1 and DEC2 regulate the paclitaxel-induced apoptotic pathway of MCF-7 human breast cancer cells. Int J Mol Med. 2011;27:491\u20135.","DOI":"10.3892\/ijmm.2011.617"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_028_w2aab3b7b1b1b6b1ab1b5c28Aa","doi-asserted-by":"crossref","unstructured":"Wu Y, Sato F, Bhawal UK, Kawamoto T, Fujimoto K, Noshiro M, et al. BHLH transcription factor DEC2 regulates pro-apoptotic factor Bim in human oral cancer HSC-3 cells. Biomed Res (Tokyo). 2012;33:75\u201382.10.2220\/biomedres.33.75","DOI":"10.2220\/biomedres.33.75"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_029_w2aab3b7b1b1b6b1ab1b5c29Aa","doi-asserted-by":"crossref","unstructured":"van der Merwe JL, Hall DR, Wright C, Schubert P, Grov\u00e9 D. Are early and late preeclampsia distinct subclasses of the disease \u2013 what does the placenta reveal? Hypertens Pregnancy. 2010;29:457\u201367.10.3109\/1064195090357228220701467","DOI":"10.3109\/10641950903572282"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_030_w2aab3b7b1b1b6b1ab1b5c30Aa","doi-asserted-by":"crossref","unstructured":"Wang L, Li X, Zhao Y, Fang C, Lian Y, Gou W, et al. Insights into the mechanism of CXCL12-mediated signaling in trophoblast functions and placental angiogenesis. Acta Biochim Biophys Sin (Shanghai). 2015;47:663\u201372.10.1093\/abbs\/gmv06426188201","DOI":"10.1093\/abbs\/gmv064"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_031_w2aab3b7b1b1b6b1ab1b5c31Aa","doi-asserted-by":"crossref","unstructured":"Freitag N, Tirado-Gonz\u00e1lez I, Barrientos G, Herse F, Thijssen VL, Weedon-Fekj\u00e6r SM, et al. Interfering with Gal-1-mediated angiogenesis contributes to the pathogenesis of preeclampsia. Proc Natl Acad Sci USA. 2013;110:11451\u20136.10.1073\/pnas.1303707110","DOI":"10.1073\/pnas.1303707110"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_032_w2aab3b7b1b1b6b1ab1b5c32Aa","doi-asserted-by":"crossref","unstructured":"Liu H, Li Y, Zhang J, Rao M, Liang H, Liu G. The defect of both angiogenesis and lymphangiogenesis is involved in preeclampsia. See comment in PubMed Commons belowPlacenta. 2015;36:279\u201386.","DOI":"10.1016\/j.placenta.2014.12.013"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_033_w2aab3b7b1b1b6b1ab1b5c33Aa","doi-asserted-by":"crossref","unstructured":"Brown MC, Best KE, Pearce MS, Waugh J, Robson SC, Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur J Epidemiol. 2013;28:1\u201319.2339751410.1007\/s10654-013-9762-6","DOI":"10.1007\/s10654-013-9762-6"},{"key":"2023040100153365698_j_jpm-2015-0437_ref_034_w2aab3b7b1b1b6b1ab1b5c34Aa","doi-asserted-by":"crossref","unstructured":"Winnik S, Lohmann C, Siciliani G, von Lukowicz T, Kuschnerus K, Kraenkel N, et al. Systemic VEGF inhibition accelerates experimental atherosclerosis and disrupts endothelial homeostasis \u2013 implications for cardiovascular safety. Int J Cardiol. 2013;168:2453\u201361.2356191710.1016\/j.ijcard.2013.03.010","DOI":"10.1016\/j.ijcard.2013.03.010"}],"container-title":["Journal of Perinatal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jpme.2017.45.issue-7\/jpm-2015-0437\/jpm-2015-0437.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2015-0437\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2015-0437\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T14:36:36Z","timestamp":1680359796000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpm-2015-0437\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11,15]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,4,13]]},"published-print":{"date-parts":[[2017,10,26]]}},"alternative-id":["10.1515\/jpm-2015-0437"],"URL":"https:\/\/doi.org\/10.1515\/jpm-2015-0437","relation":{},"ISSN":["1619-3997","0300-5577"],"issn-type":[{"value":"1619-3997","type":"electronic"},{"value":"0300-5577","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11,15]]}}}